go to contents

a:head bio AG

Back to list

Facts

Founded
2019
Staff
9
Organization type
RDM biotech/pharma
Region
Vienna
Focus
human health

Profile

a:head aims to develop new therapeutics for the treatment of brain disorders based on human cerebral organoids

R&D:a:head’s drug discovery approach is based on human cerebral organoids, a revolutionary, paradigm-shifting new technology that allows the generation of mini brains from human stem cells in vitro. They capture the essential aspects of human embryonic brain development including brain patterning, formation of brain ventricles, differentiation into the various neuronal and supportive cell types and their correct three-dimensional arrangement.

Similar companies in RDM biotech/pharma

CYL Pharmazeutika GmbH

Organization type
RDM biotech/pharma
Region
Styria
Focus
human health
Details

Annikki GmbH

Organization type
RDM biotech/pharma
Region
Styria
Focus
industrial processing
Details

OncoOne Research

Organization type
RDM biotech/pharma
Region
Lower Austria
Focus
human health
Details

BIOCRATES Life Sciences AG

Organization type
RDM biotech/pharma
Region
Tyrol
Cluster
Life Sciences Tyrol
Focus
human health
Details

Contact

Dr.-Bohr-Gasse 7, VBC6
1030 Wien
Vienna

Contact: Oliver Szolar (CEO)
Email: office@aheadbio.com
Website